Applications Of Rppa For Oncology Research And Biomarker Discovery
date14 October 2020
time & location9:30PM, Virtual
October 15, 2020 | 9:30 am CST
北京时间 10月15日, 周四上午 9:30am
(October 14, 2020 | 9:30pm EDT) Event will take place primarily in Mandarin with a brief English introduction.
You are invited to join Quanterix, in partnership with Neoline Technology Corp., as Dr. Shixia Huang of Baylor College of Medicine and Dr. Nan Wang of Flynnbio discuss Reverse Phase Protein Arrays (RPPA), which have been successfully used in various aspects of oncology research. RPPA is a robust, sensitive, and high-throughput analytical platform that can be adapted to many other fields of biomedical research.
This webinar will discuss the advantages and challenges using the RPPA technology.
Presentations will follow an introduction by Rocco Raduazo of Quanterix.
Reverse Phase Protein Array as a Discovery Platform for Cancer Research
Shixia Huang, PhD
Application of RPPA based functional proteomics in systems oncology and
Nan Wang, PhD
About the Speakers:
Dr. Shixia Huang is the director of the antibody-based proteomics core and an associate professor of molecular and cellular biology at Baylor College of Medicine.
Dr. Nan Wang has been an associated scientist of North East Proteomics Analysis Facilities (NEPAF) and development scientist at Newcastle University Protein and Proteome Analysis Lab UK (NUPPA), and technical director of ArrayGen company in the UK. Dr. Nan Wang is currently the chief technology officer of Mills Institute for Personalized Cancer Therapy at Fynn Biotechnologies.
Share this page